Kelly Paul Edward

Kelly Paul Edward is listed in filings as Director at Relmada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including purchase activity. Recent filings connect the profile to Relmada Therapeutics, Inc. (RLMD). The current snapshot covers public activity from Sep 11, 2024 to Dec 16, 2025. Reported amounts are shown as $64.8K to $268.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.